The FDA has accepted for review the NDA for bumetanide nasal spray for edema associated with CHF, as well as hepatic and renal disease.

Q. I saw the news recently that the Food and Drug Administration is proposing to remove a popular ingredient in ...

The U.S. Food and Drug Administration recently expanded approval of the nasal spray SPRAVATO, a ketamine-derived drug, as a ...

MUNICH, Germany I January 30, 2025 I Ethris GmbH, a leading biotechnology company pioneering next-generation RNA therapeutics and vaccines, today announced ...

A groundbreaking approach led by a team of scientists, including Rice University chemist James Tour, has the potential to ...

The FDA’s nod for suzetrigine bolsters confidence in the pharmaceutical industry’s strategy to target sodium channels.

PHOENIX (AZFamily) — A ketamine-derived nasal spray is now available for the millions of Americans living with severe depression. The hallucinogenic drug is an option when traditional treatment isn’t ...

For those with major depression, there is a new treatment option - one that offers hope when patients are not responding to ...

The cold weather and indoor heating can cause dryness and worsen eye discomfort Here is how you can maintain eye health during winter ...

You are reading our weekly Well+Being newsletter. Sign up here to get it delivered to your inbox every Thursday. This week, ...

A graduate of Stanford University's prestigious EENT Innovation Biodesign program in 2019, Diag-Nose.io is redefining ...